STERIS LABORATORIES INC -- 0402-0865, PILOCARPINE HYDROCHLORIDE (SUPP DA
=======================================================
Material Safety Data Sheet
=======================================================
MSDS Num: BXJSN
MSDS NAME: 0402-0865, PILOCARPINE HYDROCHLORIDE (SUPP DATA)
Responsible Party
Name: STERIS LABORATORIES INC
Address: 620 N 51ST AVE
City: PHOENIX AR 85043
Info Phone: 602-278-1400
Emergency Phone Number: 602-278-1400
Preparer's Name: JANET MEHTA
Published: Y
=======================================================
Contractor Summary
=======================================================
Name: STERIS LABORATORIES INC
Address: 620 N 51ST AVE
City: PHOENIX AZ 85043-2702
Phone: 602-278-2400
=======================================================
Ingredients
=======================================================
Cas: 54-71-7
RTECS #: TK1450000
Name: PILOCARPINE, MONOHYDROCHLORIDE; (PILOCARPINE HYDROCHLORIDE)
% Wt: 1-6
OSHA PEL: N/K (FP N)
ACGIH TLV: N/K (FP N)
=======================================================
Health Hazards Data
=======================================================
LD50 LC50 Mixture: NONE SPECIFIED BY MANUFACTURER.
Route Of Entry Inds - Inhalation: YES
Skin: YES
Ingestion: YES
Carcinogenicity Inds - NTP: NO
IARC: NO
OSHA: NO
Effects of Exposure: ACUTE:EYE, SKIN &/OR RESPIRATORY TRACT IRRITATION.
SWEATING, WATER NASAL DISCHARGE, ERUCTATION, LACRIMATION, INVOLUNTARY
DEFECATION & URINATION, FLUSHING, MIOSIS, CONJUNCTIVAL CONGESTION,
CILIARY SPAS M, HYSTAGMUS, FEAR, RESTLESSNESS, EXCESSIVE DREAMING, INCREASED
BRONCHIAL SECRETION W/BRONCHO (EFTS OF OVEREXP)
Explanation Of Carcinogenicity: NOT RELEVANT
Signs And Symptions Of Overexposure: HLTH HAZ:CONSTRICTION, BRADYCARDIA,
HYPOTENSION & COMA. ALSO, DEATH MAY OCCUR DUE TO CARDIAC ARREST, CENTRAL
RESPIRATORY PARALYSIS OR PULMONARY EDEMA. CHRONIC:POSSIBLE
HYPERSENSITIZATION.
Medical Cond Aggravated By Exposure: NONE SPECIFIED BY MANUFACTURER.
First Aid: EYE:FLUSH W/WATER FOR AT LEAST 15 MINUTES. SEEK MEDICAL
ADVICE/ATTENTION. SKIN:REMOVE CONTAMINATED CLOTHING. FLUSH W/WATER. SEEK
MEDICAL ADVICE/ATTENTION. INHAL:REMOVE PERSON TO FRESH AIR. SEEK MEDICA L
ATTENTION. INGEST:FLUSH MOUTH W/WATER. SEEK MEDICAL ADVICE/ATTENTION.
=======================================================
Handling and Disposal
=======================================================
Spill Release Procedures: WEAR THE RECOMMENDED PERSONAL PROTECTIVE EQUIPMENT.
WIPE WORKING SURFACE TO DRYNESS, THEN WASH W/SOAP & WATER.
Neutralizing Agent: NONE SPECIFIED BY MANUFACTURER.
Waste Disposal Methods: DISPOSE OF I/A/W FEDERAL, STATE & LOCAL
REGULATIONS.
Handling And Storage Precautions: HANDLE ALL PHARMACEUTICAL PRODUCTS IN A WAY
THAT WILL AVOID CONTACT WITH & INHALATION OF DUST, FUMES, MISTS &/OR
VAPORS ASSOCIATED W/THE PRODUCT.
Other Precautions: STORE IN COOL PLACE (8-27C).
=======================================================
Fire and Explosion Hazard Information
=======================================================
Extinguishing Media: WATER SPRAY, DRY CHEMICAL, CARBON DIOXIDE OR FOAM, AS
APPROPRIATE FOR SURROUNDING MATERIALS & FIRE.
Fire Fighting Procedures: USE NIOSH/MSHA APPROVED SCBA & FULL PROTECTIVE
EQUIPMENT (FP N).
Unusual Fire/Explosion Hazard: EMITS TOXIC FUMES.
=======================================================
Control Measures
=======================================================
Respiratory Protection: NIOSH/MSHA APPROVED RESPIRATOR.
Ventilation: LOCAL EXHAUST RECOMMENDED.
Protective Gloves: DISPOSABLE, SURGICAL LATEX GLOVES.
Eye Protection: ANSI APPROVED CHEM WORKERS GOGGS (FP N).
Other Protective Equipment: EYE WASH FOUNTAIN & DELUGE SHOWER WHICH MEET ANSI
DESIGN CRITERIA (FP N). DISPOSABLE PROT APPAREL (PROT EXPOSED SKIN).
Work Hygienic Practices: NONE SPECIFIED BY MANUFACTURER.
Supplemental Safety and Health: MFR'S TRADE NAME/PART NO:OPHTHALMIC SOLUTION,
USP. PH:3.5-5.5.
=======================================================
Physical/Chemical Properties
=======================================================
Spec Gravity: 1.009 (H*2O=1)
PH: SUPDAT
Solubility in Water: SOLUBLE
Appearance and Odor: CLEAR, PRACTICALLY COLORLESS SOLUTION; NO ODOR.
=======================================================
Reactivity Data
=======================================================
Stability Indicator: YES
Stability Condition To Avoid: EXPOSURE TO LIGHT MAY CAUSE DECOMPOSITION.
Materials To Avoid: AVOID SILVER NITRATE, MERCURY BICHLORIDE, IODIDES, GOLD
SALTS, TANNIN, CALOMEL, KMNO*4 & ALKALIES.
Hazardous Decomposition Products: EMITS TOXIC FUMES OF HCL & NO*X.
Hazardous Polymerization Indicator: NO
Conditions To Avoid Polymerization: NOT RELEVANT
=======================================================
Toxicological Information
=======================================================
=======================================================
Ecological Information
=======================================================
=======================================================
MSDS Transport Information
=======================================================
=======================================================
Regulatory Information
=======================================================
=======================================================
Other Information
=======================================================
=======================================================
HAZCOM Label
=======================================================
MSDS NAME: 0402-0865, PILOCARPINE HYDROCHLORIDE (SUPP DATA)
Company: STERIS LABORATORIES INC
Street: 620 N 51ST AVE
City: PHOENIX AZ
Zipcode: 85043-2702
Health Emergency Phone: 602-278-1400
Label Required IND: Y
Date Of Label Review: 05/17/1995
Status Code: C
Label Date: 05/17/1995
Origination Code: G
Eye Protection IND: YES
Skin Protection IND: YES
Signal Word: WARNING
Respiratory Protection IND: YES
Health Hazard: Moderate
Contact Hazard: Moderate
Fire Hazard: None
Reactivity Hazard: None
Hazard And Precautions: EMITS TOXIC FUMES. ACUTE:EYE, SKIN &/OR RESPIRATORY
TRACT IRRITATION. SWEATING, WATER NASAL DISCHARGE, BELCHING, TEARING,
INVOLUNTARY DEFECATION & URINATION, FLUSHING, CONTRACTION OF PUPIL OF THE
EYE, CONJUNCTIVAL CONGESTION, SPASM OF THE LENSE OF THE EYE, HYSTAGMUS,
FEAR, RESTLESSNESS, EXCESSIVE DREAMING, INCREASED BRONCHIAL SECRETION
W/BRONCHO CONSTRICTION, SLOWED HEART ACTION, HYPOTENSION & COM A. ALSO,
DEATH MAY OCCUR DUE TO CARDIAC ARREST, CENTRAL RESPIRATORY PARALYSIS OR
PULMONARY EDEMA. CHRONIC:NONE LISTED BY MANUFACTURER.
=======================================================
Disclaimer (provided with this information by the compiling agencies): This
information is formulated for use by elements of the Department of Defense.
The United States of America in no manner whatsoever expressly or implied
warrants, states, or intends said information to have any application, use or
viability by or to any person or persons outside the Department of Defense
nor any person or persons contracting with any instrumentality of the United
States of America and disclaims all liability for such use. Any person
utilizing this instruction who is not a military or civilian employee of the
United States of America should seek competent professional advice to verify
and assume responsibility for the suitability of this information to their
particular situation regardless of similarity to a corresponding Department
of Defense or other government situation.
*** END OF RECORD *** |
|
|